Company profile

Transgene, part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Transgene's programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cells. The company's three lead clinical-stage programs are: TG4010 for non-small cell lung cancer, TG4001 for HPV positive cancers and Pexa-Vec for liver cancer. Transgene has several other programs in clinical and pre-clinical development that are based on its core viral vector technology. The company is based in Strasbourg, France, and has additional operations in Lyon and China.

Source: Cofisem - Last Update: 24 May 2019
Key Executives
Chairman and Chief Executive Officer Philippe Archinard
Deputy CEO Christophe Ancel
Executive Vice President Eric Quéméneur
Company Secretary John Felitti
Chief Financial Officer Jean-Philippe Del
VP, Communication Lucie Larguier
Investor Relations Lucie Larguier
General Counsel John Felitti
Director Eric Quéméneur
Source: Cofisem - Last Update: 24 May 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 7.084 7.457 8.728 9.565 11.752
Income from ordinary activities 7.084 7.457 8.728 9.565 11.752
Operating income 7.368 -28.043 -22.664 -35.807 -46.932
Cost (net) of financial indebtedness -905 -902 -637 -341 -251
Equity-accounted companies' contribution to results 2.675 -1.944 -917 -1.172 -824
Net profit from discontinued activities -1.024 -8.465
Net income 8.026 -32.274 -25.207 -46.374 -48.556
Net income (Group share) 8.026 -32.274 -25.207 -46.374 -48.556
Fiscal year end 12,18 12,17 12,16 12,15 12,14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 24 May 2019
Shareholder information
TSGH 56,90 %
Flottant 38,40 %
Dassault Belgique Aviation 4,70 %
Source: Cofisem - Last Update: 10 Apr 2019

Address

Transgene

Parc d’Innovation 400 Boulevard Gonthier d Andernach
FR-67405 Illkirch Graffenstaden Cedex
France
Source: Cofisem - Last Update: 24 May 2019

Contact

LARGUIER Lucie
Phone number: + 33 (0) 3 88 27 91 21
Source: Cofisem - Last Update: 24 May 2019